GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (OTCPK:CVALF) » Definitions » Shiller PE Ratio

Covalon Technologies (Covalon Technologies) Shiller PE Ratio : (As of Jun. 10, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Covalon Technologies Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Covalon Technologies Shiller PE Ratio Historical Data

The historical data trend for Covalon Technologies's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Shiller PE Ratio Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Covalon Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Covalon Technologies's Shiller PE Ratio

For the Biotechnology subindustry, Covalon Technologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Shiller PE Ratio falls into.



Covalon Technologies Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Covalon Technologies's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Covalon Technologies's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.044/126.2576*126.2576
=0.044

Current CPI (Mar. 2024) = 126.2576.

Covalon Technologies Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.028 99.473 -0.036
201409 -0.091 99.394 -0.116
201412 -0.017 98.367 -0.022
201503 0.008 99.789 0.010
201506 -0.008 100.500 -0.010
201509 -0.068 100.421 -0.085
201512 0.015 99.947 0.019
201603 -0.076 101.054 -0.095
201606 -0.016 102.002 -0.020
201609 -0.130 101.765 -0.161
201612 0.022 101.449 0.027
201703 0.015 102.634 0.018
201706 0.015 103.029 0.018
201709 0.016 103.345 0.020
201712 0.016 103.345 0.020
201803 -0.015 105.004 -0.018
201806 0.069 105.557 0.083
201809 -0.023 105.636 -0.027
201812 -0.067 105.399 -0.080
201903 -0.007 106.979 -0.008
201906 -0.120 107.690 -0.141
201909 -0.121 107.611 -0.142
201912 -0.038 107.769 -0.045
202003 -0.107 107.927 -0.125
202006 0.007 108.401 0.008
202009 -0.068 108.164 -0.079
202012 -0.008 108.559 -0.009
202103 0.008 110.298 0.009
202106 0.033 111.720 0.037
202109 0.687 112.905 0.768
202112 -0.047 113.774 -0.052
202203 -0.071 117.646 -0.076
202206 -0.047 120.806 -0.049
202209 -0.120 120.648 -0.126
202212 -0.015 120.964 -0.016
202303 -0.022 122.702 -0.023
202306 -0.015 124.203 -0.015
202309 -0.089 125.230 -0.090
202312 -0.022 125.072 -0.022
202403 0.044 126.258 0.044

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Covalon Technologies  (OTCPK:CVALF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Covalon Technologies Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (Covalon Technologies) Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.